Pfizer Pays $34.7M To Settle Genotropin Charges

Law360, New York (April 2, 2007, 12:00 AM EDT) -- Pfizer Inc. has agreed to pay fines of $34.7 million to settle allegations two subsidiaries engaged in illegal off-label marketing and paid kickbacks to a vendor to boost sales of human growth hormone Genotropin, the drug maker said Monday.

Two subsidiaries of Pfizer unit Pharmacia reached separate settlements with the U.S. Department of Justice for activities that occurred at Pharmacia before it was acquired by Pfizer in 2003, Pfizer said.

One subsidiary—Pharmacia & Upjohn Company Inc.—will plead guilty to a single count of offering to an...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.